| From : | Averhoff, Francisco (CDC/DDID/NCIRD/ID) <fma0@cdc.gov> |
| To : | Gamkrelidze, Amiran (CDC ncdc.ge) <a.gamkrelidze@ncdc.ge>; Maia Tsereteli <mtsereteli2002@yahoo.com>; Ana Aslanikashvili <ana.aslanikashvili@gmail.com>; Tengiz Tsertsvadze <tt@aidscenter.ge>; akaki abutidze <akakiabutidze@yahoo.com>; Nikoloz Chkhartishvili <nc@aidscenter.ge>; Nikoloz Chkhartishvili <nikoloch@yahoo.com>; jaba zarqua <jabazarqua@gmail.com>; Maia Butsashvili <maiabutsashvili@gmail.com>; George Kamkamidze <georgekamkamidze@gmail.com>; Ekaterine Adamia <eadamia@moh.gov.ge>; Tamar Gabunia <tgabunia@moh.gov.ge> |
| Subject : | Transitions |
| Received On : | 11.08.2020 15:37 |
Dear Friends and Colleagues,
I wanted to advise you that I have left the CDC Division of Viral Hepatitis as of 1 August 2020. You have all done an amazing job with HCV Elimination, it has been my honor and privilege to work with you all. The support from CDC will
continue, of course, with the Atlanta and Georgia based teams, I look forward to the final success! I am staying and supporting the CDC COVID-19 response, which has been a huge challenge, and we again need to learn lessons from Georgia, just as we have for
HCV Elimination.
My email address remains. Thank you again for the privilege of working with you all and the opportunity to get to know you as friends and visit your beautiful and lovely country.
Best regards, FA
Francisco Averhoff MD, MPH
CAPT US Public Health Service
COVID 19 Response
Serology Coordination
Centers for Disease Control and Prevention
1600 Clifton Road
Atlanta, GA 30333
phone: 404-718-8501
e-mail:
fma0@cdc.gov